NAVA Use in Preterm Neonates With Respiratory Distress Syndrome
Condition(s) studied
Investigational drug(s) / intervention(s)
Maquet [servo-n]: ventilator settings will be recorded such as: NAVA level , Edi peak , peep, apnea time
Drager , SLE 5000, SLE 6000: ventilator settings will be recorded such as peep , PIP , Fio2
Study summary
A randomized controlled clinical trial evaluates the efficacy of NAVA in comparison with conventional ventilation (SIMV) in preterm neonates with respiratory distress syndrome.
Eligibility
Primary outcome measure(s)
- Echocardiography — baseline and after 24 hours from enrollment in the study
to assess any structural cardiac anomalies, the patency of ductus arteriosus, right ventricular output (RVO), left ventricular output (LVO), and superior vena cava (SVC) flow, ejection fraction (EF) and pulmonary pressure performed by a specialized echocardiographist.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Neonatal Intensive Care Units (NICUs), Ain Shams University | Cairo | Abbasia | Recruiting |
More Ain Shams University trials in Egypt
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07926009 on ClinicalTrials.gov ↗ ← All trials in Egypt